← Open Payments lookup

NICOLE MEZO: Open Payments

NPI 1861702441 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,223 in 57 payments from 17 companies in 2025. Trend: 2023 $806 · 2024 $1,344 · 2025 $1,223

Food & beverage: $1,115Education: $108
CompanyPaymentsAmount
GENZYME CORPORATION15$241
GlaxoSmithKline, LLC.10$181
Novartis Pharmaceuticals Corporation5$101
SANOFI-AVENTIS U.S. LLC1$100
Regeneron Healthcare Solutions, Inc.3$82
AstraZeneca Pharmaceuticals LP4$78
Ionis Pharmaceuticals, Inc.2$77
PFIZER INC.3$75
CSL Behring3$57
Takeda Pharmaceuticals U.S.A., Inc.2$45

Products named: DUPIXENT, NUCALA, DAWNZERA, OCTAGAM IMMUNE GLOBULIN (HUMAN), TEZSPIRE, TRELEGY ELLIPTA, CUVITRU, Andembry.

Industry payments across CO — which companies pay providers there.